IndraLab

Statements



reach
"Inhibition of USP8 by DUB‐IN‐3 enhanced OGT ubiquitination in a dose‐dependent manner (Figure S4C, Supporting Information)."

reach
"And the compound DUB‐IN‐3, a small molecular inhibitor of USP8, showed the most effective anti‐cancer responses."